Results 121 to 130 of about 2,428,275 (198)

CLN7 suppression induces apoptosis via mTOR-regulated and chaperone-mediated autophagy in myeloid leukemia cells. [PDF]

Cell Death Dis
Wu M, Li H, Li S, Xu Q, Liao Y, Qu L, Cang C, Wang X.   +7 more
europepmc   +1 more source

Roles of extracellular vesicles in the pathogenesis of chronic myeloid leukemia. [PDF]

J Physiol Biochem
Hrdinova T, Kupcova Skalnikova H.
europepmc   +1 more source

HIRA-SETDB1-H3K9me3 axis regulates chromatin architecture in leukemia cells. [PDF]

J Biol Chem
Shirude MB, Devarajan A, Sahu SA, Mukherjee A, Dutta D.   +4 more
europepmc   +1 more source

Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia. [PDF]

Ann Hematol
Mazzarella R, Cicconi L, Perrone S, Divona MD, Ceccolini S, Nardozza AM, Biagi A, Ottone T, Corbingi A, Panetta P, La Barbera EO, Fiori L, Romeo AA, Pacitto G, Cotroneo E, Breccia M, Voso MT, Pulsoni A.   +17 more
europepmc   +1 more source

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation. [PDF]

Nano Converg
Lugin ML, Lei W, Lee RT, Chung JY, Katritsis NM, Hwang W, Fleischman AG, Han N, Kwon YJ.   +8 more
europepmc   +1 more source

Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities. [PDF]

Cancers (Basel)
Caprino F, Valentino I, Bruzzese A, Ganino L, Mesuraca M, Citraro R, Gentile M, Gallo Cantafio ME, Amodio N.   +8 more
europepmc   +1 more source

Clinical Significance of the S348l Mutation in BCR-ABL as a Dominant Variant in Indonesian CML Patients Under Tyrosine Kinase Inhibitor Therapy: A Cohort Study. [PDF]

Asian Pac J Cancer Prev
Harjianti T, Pabbabari W, Benyamin F, Saleh S, Minhajat R, Bayu D, Seweng A.   +6 more
europepmc   +1 more source

Spectroscopic Signature of Apoptosis Induced by Venetoclax in Philadelphia-Positive Acute Lymphoblastic Leukemia. [PDF]

Anal Chem
Szewczyk M, Dawiec P, Nowakowska AM, Jakubowska J, Pastorczak A, Barańska M, Młynarski W, Majzner K, Ostrowska K.   +8 more
europepmc   +1 more source

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. [PDF]

Circulation
Jambon-Barbara C, Suissa S, Dell'Aniello S, Hlavaty A, Cracowski JL, Chaumais MC, Humbert M, Montani D, Khouri C.   +8 more
europepmc   +1 more source

Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplant. [PDF]

Clin Exp Med
Luo Y, Chen WM, Zhao XS, Chang YJ, Zhao T, Wu Y, Cheng YF, Mo XD, Sun YQ, Wang Y, Xu LP, Zhang XH, Huang XJ, Qin YZ, Lv M.   +14 more
europepmc   +1 more source